Zydus Lifesciences Limited (Formerly known as ... Cadila Healthcare announced that the company has received a warning letter by the USFDA relating to its Moraiya formulation facility and Ahmedabad ...

Zydus Life share price: Pharmaceutical company Zydus Life shares ... The buying interest in the stock came after the company received a letter of intent (LOI) from a leading wind energy company.

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The designation ...

The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb trial of its oral NLRP3 inflammasome inhibitor, Usnoflast, for ...

Zydus, a leading, discovery-based, global pharmaceutical company announced that the US FDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of ...

Outgoing presidents traditionally leave a letter for the incoming president. Former President Joe Biden wished President Donald Trump "all the best for the next four years" in the letter he left ...

WASHINGTON − Former President Joe Biden left a letter for the man replacing him in the Oval Office, continuing a tradition dating back 36 years. President Donald Trump discovered the letter ...

One 97 Communications Paytm, Zomato, APL Apollo Tubes, Central Bank of India, Dixon Technologies, IDBI Bank, Indian Overseas ...

Jan 21 (Reuters) - U.S. President Donald Trump on Tuesday said former President Joe Biden left him a "nice" letter inside the Resolute Desk at the White House, continuing an inauguration day ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Biden wrote Trump a letter but did not disclose what his message said. As President Joe Biden prepared to pass the baton to President-elect Donald Trump, he followed the tradition of leaving his ...

Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.